Murray T, Yunis A A
J Lab Clin Med. 1981 Sep;98(3):396-401.
A comparative study of the cellular transport of CAP and its nitroso derivative (NO-CAP) was carried out in Raji cells, a transformed human lymphoblastoid cell line. Both agents were concentrated by the cells by a factor of 3 (cellular/extracellular concentration ratio). The cellular uptake of NO-CAP, like that of CAP, was found to be rapid and temperature-independent. Thus the greater cytotoxicity of NO-CAP is apparently not due to an enhanced uptake of the nitroso derivative relative to CAP. In contrast to the similarity of uptake, NO-CAP becomes covalently bound to both Raji cells and freshly isolated human bone marrow cells to a much higher extent (15-fold). Also, cells previously loaded with CAP or NO-CAP retain three times as much of the nitroso compound during a 24 hr dialysis against a drug-free isotonic solution. The increased binding of NO-CAP to human hematopoietic cells attests to the greater reactivity of the p-substituted aromatic nitroso group and is consistent with the postulate that reduction products of the nitro group of CAP may be responsible for CAP-induced aplastic anemia.
在人转化淋巴母细胞系Raji细胞中对氯霉素(CAP)及其亚硝基衍生物(NO-CAP)的细胞转运进行了比较研究。两种药物在细胞内的浓度均比细胞外高3倍(细胞内/细胞外浓度比)。发现NO-CAP与CAP一样,细胞摄取迅速且与温度无关。因此,NO-CAP更大的细胞毒性显然不是由于亚硝基衍生物相对于CAP的摄取增加所致。与摄取相似性相反,NO-CAP与Raji细胞和新鲜分离的人骨髓细胞的共价结合程度要高得多(15倍)。此外,预先加载了CAP或NO-CAP的细胞在与无药物等渗溶液进行24小时透析期间,保留的亚硝基化合物是其三倍。NO-CAP与人造血细胞结合增加证明了对位取代的芳香基亚硝基基团具有更高的反应活性,这与CAP硝基还原产物可能是CAP诱导再生障碍性贫血的原因这一假设一致。